AC Immune SA — Investor Relations & Filings
AC Immune SA is a clinical-stage biopharmaceutical company specializing in precision medicine for neurodegenerative diseases. The company pioneers novel approaches to diagnose, treat, and prevent conditions driven by misfolded proteins, including Alzheimer's disease, Parkinson's disease, and other rare indications. Its diversified pipeline includes therapeutic and diagnostic candidates developed through proprietary technology platforms. These candidates encompass various treatment modalities such as active immunotherapies, antibodies, and small molecules. The company's scientific and clinical strategies are validated through collaboration partnerships with global pharmaceutical leaders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 6-K | 2026-05-15 | English | |
| 6-K - AC Immune SA (0001651625) (Filer) | 2026-05-12 | English | |
| 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-30 | English | |
| 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-30 | English | |
| 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-07 | English | |
| 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-20 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 46355480 | FORM 6-K | 2026-05-15 | English | ||
| 45255632 | 6-K - AC Immune SA (0001651625) (Filer) | 2026-05-12 | English | ||
| 39071943 | 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-30 | English | ||
| 39071207 | 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-30 | English | ||
| 33705647 | 6-K - AC Immune SA (0001651625) (Filer) | 2026-04-07 | English | ||
| 33000417 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-20 | English | ||
| 32977834 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977518 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977508 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977492 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977448 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 32977447 | 3 - AC Immune SA (0001651625) (Issuer) | 2026-03-18 | English | ||
| 31141162 | 6-K Filing | 2026-02-17 | English | ||
| 12904156 | Regulatory Filings 2026 | 2026-01-15 | English | ||
|
2025
1 filing
| |||||
| 12904157 | FORM 6-K | 2025-12-11 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for AC Immune SA, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioNxt Solutions Inc.
Clinical-stage developer of next-generation drug formulatio…
|
BNXT | CA | Manufacturing |
|
Biophage Pharma Inc.
Developing innovative phage-based therapies for antibiotic-…
|
BIPMF | CA | Manufacturing |
|
BioPorto
An in vitro diagnostics company specializing in biomarkers …
|
BIOPOR | DK | Manufacturing |
|
BIO-RAD LABORATORIES, INC.
Develops and manufactures products for life science and cli…
|
BIO | US | Manufacturing |
|
Biosergen AB
Develops drugs to treat severe and resistant invasive funga…
|
BIOSGN | SE | Manufacturing |
|
Biosino Bio-Technology and Science Incorporation
Major high-tech manufacturer of in-vitro diagnostic (IVD) p…
|
8247 | HK | Manufacturing |
|
BIOSIS GROUP BERHAD
Manufacturer of pharmaceutical, personal care, skincare, an…
|
— | MY | Manufacturing |
|
Bio Solution Co.,Ltd.
Develops cell therapies, human tissue models, and bio-labor…
|
086820 | KR | Manufacturing |
|
BioSyent Inc.
Specialty pharmaceutical company developing and commerciali…
|
RX | CA | Manufacturing |
|
Biosynex
Designs and distributes medical diagnostic solutions, inclu…
|
ALBIO | FR | Manufacturing |
AC Immune SA via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33296/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33296 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33296 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33296 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33296}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AC Immune SA (id: 33296)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.